Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
   Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells
   LEUKEMIA & LYMPHOMA
   
   M. Exner et al., "Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells", LEUK LYMPH, 42(1-2), 2001, pp. 239-241
2. Sperr, WR; Wimazal, F; Kundi, M; Fonatsch, C; Thalhammer-Scherrer, R; Schernthaner, GH; Schwarzinger, I; Haas, OA; Geissler, K; Lechner, K; Valent, P
   Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems
   ANNALS OF HEMATOLOGY
   
   W.R. Sperr et al., "Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems", ANN HEMATOL, 80(5), 2001, pp. 272-277
3. Traunmuller, F; Thalhammer-Scherrer, R; Locker, GJ; Losert, H; Schmid, R; Staudinger, T; Thalhammer, F
   Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients
   Journal of antimicrobial chemotherapy
   
   F. Traunmuller et al., "Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients", J ANTIMICRO, 47(2), 2001, pp. 229-231
4. Wimazal, F; Sperr, WR; Kundi, M; Meidlinger, P; Fonatsch, C; Jordan, JH; Thalhammer-Scherrer, R; Schwarzinger, I; Geissler, K; Lechner, K; Valent, P
   Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes
   LEUKEMIA RESEARCH
   
   F. Wimazal et al., "Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes", LEUK RES, 25(4), 2001, pp. 287-294
5. Wagner, T; Fritsch, G; Thalhammer, R; Hocker, P; Lanzer, G; Lechner, K; Geissler, K
   IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+cells
   TRANSFUSION
   
   T. Wagner et al., "IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+cells", TRANSFUSION, 41(5), 2001, pp. 659-666
6. Ruzicka, K; Veitl, M; Thalhammer-Scherrer, R; Schwarzinger, I
   The new hematology analyzer Sysmex XE-2100 - Performance evaluation of a novel white blood cell differential technology
   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
   
   K. Ruzicka et al., "The new hematology analyzer Sysmex XE-2100 - Performance evaluation of a novel white blood cell differential technology", ARCH PATH L, 125(3), 2001, pp. 391-396
7. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
   Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)
   LEUKEMIA & LYMPHOMA
   
   K. Laczika et al., "Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)", LEUK LYMPH, 36(5-6), 2000, pp. 625-629
8. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
   Fludarabine therapy in Waldenstrom's macroglobulinemia
   ANNALS OF HEMATOLOGY
   
   R. Thalhammer-Scherrer et al., "Fludarabine therapy in Waldenstrom's macroglobulinemia", ANN HEMATOL, 79(10), 2000, pp. 556-559
9. Grumbeck, E; Aiginger, P; Gisslinger, B; Geissler, K; Thalhammer-Scherrer, R; Gisslinger, H
   Macrocytic anemia and thrombocytosis associated with thymoma: A case report
   AMERICAN JOURNAL OF HEMATOLOGY
   
   E. Grumbeck et al., "Macrocytic anemia and thrombocytosis associated with thymoma: A case report", AM J HEMAT, 63(1), 2000, pp. 38-41
10. Exner, M; Thalhammer, R; Kapiotis, S; Mitterbauer, G; Knobl, P; Haas, OA; Jager, U; Schwarzinger, I
    The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?
    CYTOMETRY
    
    M. Exner et al., "The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?", CYTOMETRY, 42(2), 2000, pp. 106-109
11. Thalhammer-Scherrer, R; Veitl, M; Exner, M; Schneider, B; Geissler, K; Simonitsch, I; Schwarzinger, I
    Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice
    CYTOMETRY
    
    R. Thalhammer-Scherrer et al., "Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice", CYTOMETRY, 42(1), 2000, pp. 5-10
12. Schmaldienst, S; Traunmuller, F; Burgmann, H; Rosenkranz, AR; Thalhammer-Scherrer, R; Horl, WH; Thalhammer, F
    Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    S. Schmaldienst et al., "Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes", EUR J CL PH, 56(1), 2000, pp. 61-64
13. Agis, H; Weltermann, A; Mitterbauer, G; Thalhammer, R; Edelhauser, M; Seewann, HL; Valent, P; Lechner, K; Fonatsch, C; Geissler, K
    Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
    ANNALS OF HEMATOLOGY
    
    H. Agis et al., "Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia", ANN HEMATOL, 78(7), 1999, pp. 329-332
14. Thalhammer-Scherrer, R; Wieselthaler, G; Knoebl, P; Schwarzinger, I; Simonitsch, I; Mitterbauer, G; Berlakovich, GA; Mannhalter, C; Haas, OA; Mayer, G; Muehlbacher, F; Wolner, E; Klepetko, W; Lechner, K; Jaeger, U
    Post-transplant acute myeloid leukemia (PT-AML)
    LEUKEMIA
    
    R. Thalhammer-Scherrer et al., "Post-transplant acute myeloid leukemia (PT-AML)", LEUKEMIA, 13(3), 1999, pp. 321-326
15. Mitterbauer, G; Zimmer, C; Fonatsch, C; Haas, OA; Thalhammer-Scherrer, R; Schwarzinger, I; Kahls, P; Jaeger, U; Lechner, K; Mannhalter, C
    Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR
    LEUKEMIA
    
    G. Mitterbauer et al., "Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR", LEUKEMIA, 13(10), 1999, pp. 1519-1524
16. Thalhammer, F; Traunmuller, F; El Menyawi, I; Frass, M; Hollenstein, UM; Locker, GJ; Stoiser, B; Staudinger, T; Thalhammer-Scherrer, R; Burgmann, H
    Continuous infusion versus intermittent administration of meropenem in critically ill patients
    Journal of antimicrobial chemotherapy
    
    F. Thalhammer et al., "Continuous infusion versus intermittent administration of meropenem in critically ill patients", J ANTIMICRO, 43(4), 1999, pp. 523-527
17. Berer, A; Ohler, L; Simonitsch, I; Thalhammer, R; Lechner, K; Geissler, K
    Long term improvement of hematopoiesis following cyclosporine treatment ina patient with myelodysplastic syndrome
    WIENER KLINISCHE WOCHENSCHRIFT
    
    A. Berer et al., "Long term improvement of hematopoiesis following cyclosporine treatment ina patient with myelodysplastic syndrome", WIEN KLIN W, 111(19), 1999, pp. 815-818
18. THALHAMMER R; BRAUN S; DEVCICKUHAR B; GROSCHL M; TRAMPLER F; BENES E; NOWOTNY H; KOSTAL M
    VISCOSITY SENSOR UTILIZING A PIEZOELECTRIC THICKNESS-SHEAR SANDWICH RESONATOR
    IEEE transactions on ultrasonics, ferroelectrics, and frequency control
    
    R. Thalhammer et al., "VISCOSITY SENSOR UTILIZING A PIEZOELECTRIC THICKNESS-SHEAR SANDWICH RESONATOR", IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 45(5), 1998, pp. 1331-1340
19. GEISSLER K; KOLLER E; HUBMANN E; NIEDERWIESER D; HINTERBERGER W; GEISSLER D; KYRLE P; KNOBL P; PABINGER I; THALHAMMER R; SCHWARZINGER I; MANNHALTER C; JAEGER U; HEINZ R; LINKESCH W; LECHNER K
    GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY
    Blood
    
    K. Geissler et al., "GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY", Blood, 90(2), 1997, pp. 590-596
20. SCHOLTEN C; FODINGER M; MITTERBAUER M; LACZIKA K; MITTERBAUER G; HAAS OA; KNOBL P; SCHWARZINGER I; THALHAMMER R; PURTSCHER B; GEISSLER K; MANNHALTER C; LECHNER K; JAEGER U
    KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    Annals of hematology
    
    C. Scholten et al., "KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA", Annals of hematology, 71(4), 1995, pp. 155-160
21. DRACH J; ANGERLER J; SCHUSTER J; ROTHERMUNDT C; THALHAMMER R; HAAS OA; JAGER U; FIEGL M; GEISSLER K; LUDWIG H; HUBER H
    INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHYOF UNDETERMINED SIGNIFICANCE
    Blood
    
    J. Drach et al., "INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHYOF UNDETERMINED SIGNIFICANCE", Blood, 86(10), 1995, pp. 3915-3921